Skip to main content

In this Issue

  • MarketHub Retail Services’ Patterson talks hemp

    Hemp-derived cannabidiol, or CBD/hemp Extract. Just talking about these kinds of things sounds intimidating, illegal and not very consumer-friendly. Skeptical? Not a problem. 
     
    It’s likely most retailers have tremendous experience with health-and-wellness products. Retail markets, consumer products and shopper marketing programs are my sandbox. Therefore, merchants are familiar with adaptogens and their many positive effects on the human body. The CBD molecule is an adaptogen.
     
  • Editor's note: Staying a step ahead of Amazon

    Whether CVS buys health insurer Aetna or not, any retailer that operates a pharmacy is about to see a dramatic change in how it competes in the future. 

  • OmniSYS’ John King on making a difference with the pharmacy

    The pharmacy’s role in healthcare delivery continues to expand as the demand for cost-effective, convenient and accessible care continues to grow. A key aspect of this new role is the growth of pharmacy-based immunization delivery.
      
  • Natureplex’s Victor Santos emphasizes OTC value

    Natureplex products
     
    With offerings that include well-known brands, and formulas for private label and contract manufacturing service, Natureplex is aiming to deliver for consumers where it matters — quality, quantity and price. Drug Store News spoke to Victor Santos, president of the Olive Branch, Miss.-based company, about its American-made bona fides, how retailers can reach OTC shoppers and what the category’s future holds.  
     
  • National digestive brands see mixed sales results

    The upper gastrointestinal proton pump inhibitors segment saw a 9% decrease — national brands only — in sales in multi-outlets for the latest 12 months compared with the previous year, with losses primarily driven down by large decreases at Procter & Gamble’s Prilosec OTC (-13%) and for GSK Consumer Heathcare’s Prevacid (-15%).

  • Editor’s note: A new journey

    Why here? And Why now?

    Two great questions as I begin my journey as the editor in chief of Drug Store News. Why here is an easy one. I am joining one of the premier retail business publications in the land, one that has a long and storied record of closely covering the rapidly changing and pretty complex chain pharmacy industry over the years. DSN has a well-deserved reputation for keeping retailers and suppliers in the know of what is going on now, as well as what may be happening down the line.

  • Q&A: Anda’s Chip Phillips talks company’s 25-year growth

    October marks Anda’s 25th anniversary of providing pharmaceutical distribution throughout the nation. Drug Store News spoke with Anda president Chip Phillips about how the company and industry has changed over a quarter of a century.
  • Consumers aiming to improve pet health

    Consumers are increasingly weighing the health consequences of all of their purchasing decisions, including products for their four-legged family members.

    From food and treats to toys and grooming products, shoppers are seeking items for their pets that offer the same healthy attributes as the products they buy for themselves.

X
This ad will auto-close in 10 seconds